On Nov 02, major Wall Street analysts update their ratings for $Teleflex (TFX.US)$, with price targets ranging from $227 to $285.
Morgan Stanley analyst Patrick Wood maintains with a buy rating, and maintains the target price at $275.
BofA Securities analyst Craig Bijou maintains with a hold rating.
Needham analyst Michael Matson maintains with a hold rating.
Raymond James analyst Jayson Bedford maintains with a buy rating, and adjusts the target price from $272 to $245.
Truist Financial analyst Richard Newitter maintains with a hold rating, and adjusts the target price from $255 to $227.
Furthermore, according to the comprehensive report, the opinions of $Teleflex (TFX.US)$'s main analysts recently are as follows:
Teleflex's third-quarter revenue shortfall is partly due to an unexpected loss of an OEM customer and softer performance in UroLift. Nonetheless, the underlying business fundamentals are believed to remain solid, and the trajectory for margin growth is expected to continue.
Following Teleflex's 'mixed' Q3 report, near-term pressures are expected to continue. Nonetheless, the outlook for the company's Urology with Pallette is seen as favorable.
Here are the latest investment ratings and price targets for $Teleflex (TFX.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
